NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ:
Post# of 174
Trxade Group (NASDAQ: MEDS), an integrated drug and healthcare platform, was recently added to the Russell Microcap Index, which helps raise its profile among investors, furthering its reach to generate long-term shareholder value while limiting marketing expenses. A recent article quotes Trxade Chairman and CEO Suren Ajjarapu about the Russell listing, stating, “This marks an exciting capital markets milestone in the growth and trajectory of our company as we continue to execute upon our growth strategy and raise awareness about the Company throughout the investment community.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer